Ark Invest Says: Watch These 5 Things (genomics revolution)

🚀 SUPPORT THE CHANNEL ON PATREON

BECOME A MEMBER OF THE CHANNEL

CHANNEL MERCH

AFFILIATES
◆ Get 2 Free Stocks (one of them up to $1600) on WeBull:
◆ Get 1 Free Stock on Stake:
◆ Get 1 Month Free Premium Access (valued at $10) to HyperCharts:

GEAR

MY TOP INVESTING/FINANCE BOOKS (listen for FREE with an audible trial)

MY TOP BOOKS

SOCIAL

SOURCE

Tags: #ArkInvest #Genomics #Arkg #CRISPR #CRSRP

In this video I react comments from analysts at Ark Invest about 5 areas to keep an eye on the the genomics space.

As always, in this video I'm just sharing my #investment thinking process and my reasoning. Keep using your own brain. Don't be a sheep. 🐑

I love you all,
Steven

p.s. Share your thoughts below. I read ALL your comments.

[SolvingTheMoneyProblem]

Do you own any genomics stocks or ETFs?

[propellerhead]

BNGO, ARKG, CRSP, EDIT, SGMO, NVTA, NTLA, and for longevity AGE and LCTX.

[sinanb.]

Solving the Money Problem....
No Money no Problems

[spelare]

Owning CRSPR, EDIT, INTELLIA, BNGO, PACBIO and some others. I keep averaging in....

[bobsalita]

Nice job by Ark of presenting technical products in a clear and compelling manner.

[Laupau]

I've been into NVTA for over 8 months and recently got into BNGO, PACB and FLGT.
Very interesting sector.

[jamesloveridgephotography]

Got in to CRSP at $150 and $200. Currently down 20% but holding for 10+ years.

No dollar left to buy the dip and average down at the moment

[InvestwithHenry]

Genomics revolution is going to crush it but Tesla on sale today.

[andyfrieden]

I have ARKG, BNGO, CRSP, PACB, and NTLA.

[TheSavlow]

Just bought 3 shares in Crispr!
Cheers for the heads up bro

[Joe]

ARKG, CRSP, PACB, NVTA, TWST, BNGO, NTLA. Also picked up CAPA (QuantumSi) recently.

[thespeculr]

Steven, an estimated 1, 806, 590 new cancer cases will be diagnosed in USA 2020 and 606, 520 people will die from cancer. I'd like to see you do a video that estimates the potential addressable cancer market for genetic therapy only. I currently own NTLA, BEAM, CRSP, EDIT

[tekila]

ABCL got cheaper. Currently holding BNGO, PACB and ArkG. Looking an entry point for Crisper.

[ishish]

I think beam has a safer method than Crispr. Less room for error. But I hold both.

[salty_berserker_channel]

Vertex pharmaceutical VRTX. Note that CRSPR therapeutics is dependent on vertex technologies. Vertex also has a very very solid balance sheet, cash on hand, and reputation. Last i looked they were #8 of ArKQ holdings

[danschraufnagel]

As I have mentioned on this channel several times, I own ARKG, CRSP, NTLA, PACB, and GENE. I view ARKG as a savings account while I decide who is the lead dog in this race. The genomic therapeutic race is really between CRSP and NTLA, in my view. CRSP is in the lead right now and has very promising clinical trials in place. I like their pipeline and have them overweight in my portfolio. NTLA is second. I have researched EDIT, but they seems even further behind to NTLA & CRSP. I view GENE and PACB as genomic diagnostics plays, not therapeutics.

[theknifedude]

So far I only have a couple of genomic stocks, ARK G and BNGO. A few medical device companies and a couple of pharmas. Most of my portfolio is in TSLA. I want to get some ARK X when that becomes available and keep my eyes open for others in the genomics sector.

[eomoran]

Didn't Cathie Say Moore's law is incorrect? That Wright's law (cost to produce halves as volume doubles) is the actual law which applies to both genomes and batteries etc

[jamesdobson]

All of these areas within Genomics are very interesting long-term, high-upside opportunities. In terms of which ones might begin to take off sooner than others, I think it stands to reason it would be in the area of DNA Sequencing: If the development of Genomics-related therapeutics or CRSPR are contingent on the collection of a massive amount of genetic data, then it strikes me that DNA Sequencing is a first and necessary step in this whole process. And if Pacific Biosciences is the only major company doing “long read” sequencing, which is far superior to “short read, ” then PACB is the horse I’m probably going to ride.

[wb]

I am invested in Tesla, Ark G and Crispr. A small portion of my portfolio is in the cannabis industry as well. You released the video of your addition of Crispr to your portfolio the day after I did, it felt reassuring to see that! I have been watching all of your Tesla, Crisper, SpceX, Starlink etc videos. I think we share the same outlook. Keep it up, thank's for all of the information Steven!